DVC
Conditions
Interventions
Experimental group:TCHG dressing
control group:Tegaderm standard dressing
Sponsors
Ruijin Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years; 2. Patient supposed to stay in ICU more than 3 days; 3. Has signed the Informed Consent form; 4. Anticipated to require Central Venous Catheters (CVC) with/without PICCO catheters or dialysis catheters; 5. Has a catheter insertion site free of deformities, phlebitis, infiltration, dermatitis, burns, or lesions; 6. Demonstrates cooperation with the DVC insertion and the securement and caring per protocol.
Exclusion criteria
Exclusion criteria: 1. Subject cant or unwilling to have visit; 2. Catheters inserted suspicious of infection judged by investigator based upon insertion setting, catheters carrying day and insertion location; 3. Has a documented or known allergy (sensitivity) to products with adhesives, e.g. transparent film adhesive dressings and CHG; 4. A current or past participant in this study; 5. Requires the application of a topical ointment or solution under the Tegaderm CHG dressing or Tegaderm standard dre.ssing in addition to the prep required in the protocol; 6. Patients with exiting BSI; 7. Pregnant or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of CVC tip colonization;Rate of DVC site skin colonization; | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive cultured CVC tip cases per 1000 catheters days;Rate of CLABSI;Dressing performance;Safety performance; | — |
Countries
China
Contacts
Public ContactYang Ye
3M China
Outcome results
None listed